+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genital Herpes Treatment Market - Global Forecast 2025-2030- Product Image
Genital Herpes Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Genital Herpes Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6016198
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Genital Herpes Treatment Market is evolving swiftly in response to medical, technological, and regulatory change, presenting new pathways for growth and optimization for stakeholders in healthcare and pharmaceuticals. Industry leaders navigating this complex terrain are seeking data-driven analysis to inform targeted decisions and maximize patient care outcomes.

Market Snapshot: Genital Herpes Treatment Market Trends and Growth

The Genital Herpes Treatment Market grew from USD 2.17 billion in 2024 to USD 2.28 billion in 2025. The market is projected to expand at a CAGR of 4.93%, achieving a value of USD 2.90 billion by 2030. This steady upward trend reflects ongoing innovations in therapeutic strategies, broad adoption of generics, and expanding patient access worldwide. Market dynamics are shaped by integration of digital health, evolving patient management paradigms, and increasing emphasis on personalized care approaches.

Scope & Segmentation

This report provides detailed segmentation and comprehensive analysis across all major components shaping the Genital Herpes Treatment Market, empowering senior decision-makers with actionable insights.

  • Molecules: Acyclovir (Branded, Generic), Famciclovir (Branded, Generic), Valacyclovir (Branded, Generic)
  • Therapy Models: Episodic Therapy, Prophylactic Therapy, Suppressive Therapy
  • Distribution Channels: Private Hospital Pharmacy, Public Hospital Pharmacy, Manufacturer Direct Online Pharmacy, Third Party E-retailer Online Pharmacy, Chain Retail Pharmacy, Independent Retail Pharmacy
  • Routes of Administration: Intravenous Home Infusion, Intravenous Hospital Administration, Oral Capsules, Oral Liquid, Oral Tablets, Topical Cream, Topical Ointment
  • End Users: Homecare (Nurse-administered, Self-administered), Private Hospitals, Public Hospitals, Dermatology Clinics, STD Clinics
  • Indications: Asymptomatic Shedding, Primary Infection (Adults, Pediatrics), Recurrent Episodes (First Recurrence, Multiple Recurrences)
  • Regions Covered: Americas (United States including key states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, UAE, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and others)
  • Company Coverage: Analysis of leading companies, including GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, Viatris Inc, Hikma Pharmaceuticals plc, Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Lupin Limited, Aurobindo Pharma Limited, Cipla Limited

Key Takeaways: Strategic Insights for Decision-Makers

  • Treatment regimens are transitioning toward more patient-centric models, combining episodic and suppressive therapies based on individual disease progression and patient preference.
  • Broader adoption of telemedicine and digital health is redefining access to diagnosis and therapy, improving convenience and adherence especially among digitally engaged patient groups.
  • Development of extended-release and new topical agents is supporting therapy compliance, highlighting the industry's focus on innovative delivery systems.
  • Generic market expansion is increasing competition, resulting in greater affordability and access to essential antivirals across diverse healthcare systems.
  • Collaborative initiatives among diagnostics developers, pharma manufacturers, and digital solution providers are driving improvement in therapeutic precision and patient outcomes.
  • Regional disparities in healthcare infrastructure and reimbursement policies necessitate tailored launch and distribution strategies to maximize market penetration and efficient resource allocation.

Tariff Impact: Navigating the 2025 Regulatory Shift

Recent adjustments to United States tariff structures on pharmaceutical imports have introduced new challenges for the supply chain and clinician access. Manufacturers are recalibrating sourcing and local production strategies to manage input costs and safeguard supply continuity. Healthcare providers must adapt to shifting price dynamics by reassessing formulary decisions and maintaining patient affordability amid these regulatory adjustments.

Market Research Methodology & Data Integrity

This research draws on primary interviews with clinicians, key opinion leaders, and supply chain experts, complemented by review of scientific literature, clinical trials, industry guidelines, and up-to-date regulatory documents. Quantitative analysis utilizes triangulation of sales data, tariff records, and healthcare reports. Segmentation and regional models are validated by macroeconomic indicators to contextualize all findings.

Why This Report Matters

  • Informs tactical and strategic planning by offering granular segmentation and regional insights into the Genital Herpes Treatment Market.
  • Supports risk management and resource allocation decisions by clarifying tariff impacts, competitive landscape, and technology adoption trends.
  • Equips senior leadership with actionable intelligence to shape R&D priorities, product positioning, and partnership strategies.

Conclusion

The Genital Herpes Treatment Market is advancing through a period of significant transformation. Industry leaders equipped with robust analytics and clear market segmentation are best positioned to drive enhanced patient outcomes and sustained business performance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of long-acting antiviral therapies for reducing recurrent genital herpes outbreaks
5.2. Growing investment in therapeutic vaccines aimed at preventing viral shedding transmission
5.3. Expansion of telehealth services facilitating remote diagnosis and prescription for herpes management
5.4. Increased focus on personalized medicine leveraging genomic profiling to tailor antiviral regimens
5.5. Emergence of novel topical microbicide formulations enhancing mucosal delivery and patient adherence
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Genital Herpes Treatment Market, by Molecule
8.1. Introduction
8.2. Acyclovir
8.2.1. Branded
8.2.2. Generic
8.3. Famciclovir
8.3.1. Branded
8.3.2. Generic
8.4. Valacyclovir
8.4.1. Branded
8.4.2. Generic
9. Genital Herpes Treatment Market, by Therapy Model
9.1. Introduction
9.2. Episodic Therapy
9.3. Prophylactic Therapy
9.4. Suppressive Therapy
10. Genital Herpes Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.2.1. Private Hospital Pharmacy
10.2.2. Public Hospital Pharmacy
10.3. Online Pharmacy
10.3.1. Manufacturer Direct
10.3.2. Third Party E-retailer
10.4. Retail Pharmacy
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
11. Genital Herpes Treatment Market, by Route Of Administration
11.1. Introduction
11.2. Intravenous
11.2.1. Home Infusion
11.2.2. Hospital Administration
11.3. Oral
11.3.1. Capsules
11.3.2. Liquid
11.3.3. Tablets
11.4. Topical
11.4.1. Cream
11.4.2. Ointment
12. Genital Herpes Treatment Market, by End User
12.1. Introduction
12.2. Homecare Settings
12.2.1. Nurse-administered
12.2.2. Self-administered
12.3. Hospitals
12.3.1. Private
12.3.2. Public
12.4. Specialty Clinics
12.4.1. Dermatology Clinics
12.4.2. STD Clinics
13. Genital Herpes Treatment Market, by Indication
13.1. Introduction
13.2. Asymptomatic Shedding
13.3. Primary Infection
13.3.1. Adults
13.3.2. Pediatrics
13.4. Recurrent Episodes
13.4.1. First Recurrence
13.4.2. Multiple Recurrences
14. Americas Genital Herpes Treatment Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Genital Herpes Treatment Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Genital Herpes Treatment Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. GlaxoSmithKline plc
17.3.2. Teva Pharmaceutical Industries Ltd
17.3.3. Sandoz International GmbH
17.3.4. Viatris Inc
17.3.5. Hikma Pharmaceuticals plc
17.3.6. Dr. Reddy's Laboratories Ltd
17.3.7. Sun Pharmaceutical Industries Ltd
17.3.8. Lupin Limited
17.3.9. Aurobindo Pharma Limited
17.3.10. Cipla Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. GENITAL HERPES TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GENITAL HERPES TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. GENITAL HERPES TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. GENITAL HERPES TREATMENT MARKET: RESEARCHAI
FIGURE 28. GENITAL HERPES TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 29. GENITAL HERPES TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 30. GENITAL HERPES TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GENITAL HERPES TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY EPISODIC THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY EPISODIC THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PROPHYLACTIC THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PROPHYLACTIC THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SUPPRESSIVE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SUPPRESSIVE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MANUFACTURER DIRECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MANUFACTURER DIRECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THIRD PARTY E-RETAILER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THIRD PARTY E-RETAILER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOME INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOME INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY OINTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY OINTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY NURSE-ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY NURSE-ADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PUBLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY STD CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY STD CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ASYMPTOMATIC SHEDDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ASYMPTOMATIC SHEDDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FIRST RECURRENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FIRST RECURRENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MULTIPLE RECURRENCES, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MULTIPLE RECURRENCES, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 227. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 228. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 229. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2024 (USD MILLION)
TABLE 230. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2025-2030 (USD MILLION)
TABLE 231. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2024 (USD MILLION)
TABLE 232. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2025-2030 (USD MILLION)
TABLE 233. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2024 (USD MILLION)
TABLE 234. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2025-2030 (USD MILLION)
TABLE 235. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2024 (USD MILLION)
TABLE 236. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2025-2030 (USD MILLION)
TABLE 237. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 242. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 243. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 244. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 245. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 248. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 249. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 250. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 251. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 252. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 253. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 256. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 257. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 258. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 259. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 260. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 261. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 262. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 263. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2024 (USD MILLION)
TABLE 264. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2025-2030 (USD MILLION)
TABLE 265. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2024 (USD MILLION)
TABLE 266. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2025-2030 (USD MILLION)
TABLE 267. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 268. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 269. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2024 (USD MILLION)
TABLE 270. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2025-2030 (USD MILLION)
TABLE 271. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2024 (USD MILLION)
TABLE 272. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2025-2030 (USD MILLION)
TABLE 273. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2024 (USD MILLION)
TABLE 274. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2025-2030 (USD MILLION)
TABLE 275. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2024 (USD MILLION)
TABLE 276. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2025-2030 (USD MILLION)
TABLE 277. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 280. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 281. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 282. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 283. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 284. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 285. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 288. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 289. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 290. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 291. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 292. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 293. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 296. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 297. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 298. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 299. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 300. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 301. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 302. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 303. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2024 (USD MILLION)
TABLE 304. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2025-2030 (USD MILLION)
TABLE 305. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2024 (USD MILLION)
TABLE 306. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2024 (USD MILLION)
TABLE 316. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2025-2030 (USD MILLION)
TABLE 317. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 320. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 321. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 322. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 323. BRAZIL GENITAL HERPES TR

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Genital Herpes Treatment market report include:
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd
  • Sandoz International GmbH
  • Viatris Inc
  • Hikma Pharmaceuticals plc
  • Dr. Reddy's Laboratories Ltd
  • Sun Pharmaceutical Industries Ltd
  • Lupin Limited
  • Aurobindo Pharma Limited
  • Cipla Limited

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.28 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.9 Billion
Compound Annual Growth Rate4.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Genital Herpes Treatment Drug Market - Global Forecast 2025-2030 - Product Image

Genital Herpes Treatment Drug Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Genital Herpes Market Report 2025 - Product Image

Genital Herpes Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Genital Herpes - Pipeline Insight, 2025 - Product Image

Genital Herpes - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Herpes Simplex Epidemiology Forecast 2025-2034 - Product Image

Herpes Simplex Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Herpes Simplex - Pipeline Insight, 2025 - Product Image

Herpes Simplex - Pipeline Insight, 2025

  • Drug Pipelines
  • 75 Pages
  • Global
From

About the Genital Herpes Drug Market

The Genital Herpes Drug market is a subset of the larger Infectious Diseases Drugs market. Genital Herpes is a sexually transmitted infection caused by the herpes simplex virus (HSV). Treatment for genital herpes includes antiviral medications, which can reduce the severity and duration of symptoms. These drugs can also reduce the risk of transmitting the virus to others. Commonly prescribed medications include acyclovir, valacyclovir, and famciclovir. These drugs are available in both oral and topical forms. The Genital Herpes Drug market is highly competitive, with many companies offering similar products. Major players in the market include GlaxoSmithKline, Novartis, Merck, Pfizer, and Sanofi. Other companies include Mylan, Teva Pharmaceuticals, and Cipla. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.